Find Federal Grants
Health Resources and Services Administration · HRSA-24-033
Environmental Protection Agency · EPA-I-OLEM-OBLR-23-15
FY24 GUIDELINES FOR BROWNFIELD ASSESSMENT GRANTS (COMMUNITY-WIDE ASSESSMENT GRANTS FOR STATES AND TRIBES)
Environmental Protection Agency · EPA-I-OLEM-OBLR-23-14
Environmental Protection Agency · EPA-OLEM-OBLR-23-13
Environmental Protection Agency · EPA-OLEM-OBLR-23-12
DARPA - Microsystems Technology Office · HR001123S0052
Environmental Protection Agency · EPA-OLEM-OBLR-23-11
2024 Effects of Sea Level Rise
Department of Commerce · NOAA-NOS-NCCOS-2024-2008163
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-278
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-277
FY2023 Historic Preservation Fund- African American Civil Rights - AACRN Preservation
National Park Service · P23AS00496
Request for Information Sustainable Aviation Fuel (SAF) Grand Challenge: Building Supply Chains
Golden Field Office · DE-FOA-0003157
Agricultural Marketing Service · USDA-FSA-OA-FLSP-G-23-0001
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-25-017
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-25-016
Solar-thermal Fuels and Thermal Energy Storage via Concentrated Solar-thermal Energy
Golden Field Office · DE-FOA-0003080
Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-25-015
Notice of Intent to issue Critical Materials Accelerator Funding Opportunity Announcement
Golden Field Office · DE-FOA-0003154
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional)
National Institutes of Health · RFA-MH-24-332
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional)
National Institutes of Health · RFA-MH-24-331